ArticlePloS one2024
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells.
Daniela Russo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticlePloS one2024
Daniela Russo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.